| 项目编号 |
PRJCA047717 |
| 项目标题 |
Enhancement of Therapeutic Efficacy by Exploiting Vulnerabilities in PDAC |
| 涉及领域 |
Medical |
| 数据类型 |
Whole genome sequencing
|
| 物种名称 |
|
| 描述信息 |
Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive malignancy, is predominantly driven by mutations in KRAS, particularly KRAS G12D, which occurs in approximately 40% of cases. This underscores the need for more effective treatment strategies. In this study, we performed WES of multiple cell lines to explore enhanced therapeutic efficacy. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2025-12-27 |
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| National Natural Science Foundation of China (NSFC)
|
|
82272757
|
|
|
|
| 提交者 |
Min
Deng (dengmin@cicams.ac.cn)
|
| 提交单位 |
Peking Union Medical College |
| 提交日期 |
2025-10-10 |
